Felipe, L. S., Vercruysse, T., Sharma, S., Ma, J., Lemmens, V., Looveren, D. van, Javarappa, M. P. A., Boudewijns, R., Malengier-Devlies, B., Kaptein, S. F., Liesenborghs, L., Keyzer, C. D., Bervoets, L., Rasulova, M., Seldeslachts, L., Jansen, S., Yakass, M. B., Quaye, O., Li, L.-H., … Dallmeier, K. (2020). A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate. BioRxiv, 2020.07.08.193045. https://doi.org/10.1101/2020.07.08.193045

LeslieMay. 14, M., 2020, & Pm, 9:00. (2020, May 14). T cells found in COVID-19 patients ‘bode well’ for long-term immunity. Science | AAAS. https://www.sciencemag.org/news/2020/05/t-cells-found-covid-19-patients-bode-well-long-term-immunity

Rahvy, A., & Ridlo, I. A. (2020). A Timeline Response: How Does Islamic Organizations Respond to COVID-19 in Indonesia? https://doi.org/10.31235/osf.io/kzhy9

Zhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., Wang, W.-J., Wu, S.-P., Wang, Z., Wu, X.-H., Xu, J.-J., Zhang, Z., Jia, S.-Y., Wang, B.-S., Hu, Y., Liu, J.-J., … Chen, W. (2020). Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: A randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31605-6

Corbett, K. S., Edwards, D. K., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K. H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch, E. J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B. M., … Graham, B. S. (2020). SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature, 1–8. https://doi.org/10.1038/s41586-020-2622-0

Walls, A. C., Fiala, B., Schäfer, A., Wrenn, S., Pham, M. N., Murphy, M., Tse, L. V., Shehata, L., O’Connor, M. A., Chen, C., Navarro, M. J., Miranda, M. C., Pettie, D., Ravichandran, R., Kraft, J. C., Ogohara, C., Palser, A., Chalk, S., Lee, E.-C., … King, N. P. (2020). Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. BioRxiv, 2020.08.11.247395. https://doi.org/10.1101/2020.08.11.247395

Nature. (2020, April 17). Coronapod: Troubling news. https://play.acast.com/s/nature/coronapod-troublingnews

Barber, C. (n.d.). ‘Instant Coffee’ COVID-19 Tests Could Be the Answer to Reopening the U.S. Scientific American. Retrieved August 27, 2020, from https://www.scientificamerican.com/article/instant-coffee-covid-19-tests-could-be-the-answer-to-reopening-the-u-s/

Science Facebook Live: Understanding SARS-CoV-2 structure informs vaccine design, clinical trials. (2020, March 20). https://www.youtube.com/watch?v=nOzEx3OpKe8

University, © Stanford, Stanford, & Complaints, C. 94305 C. (n.d.). Virality Project (US): Marketing meets Misinformation. Retrieved 25 August 2020, from https://cyber.fsi.stanford.edu/io/news/manufacturing-influence-0

Daas, Chantal den, Gill Hubbard, Marie Johnston, and Diane Dixon. ‘Protocol CHARIS Study’. Preprint. PsyArXiv, 19 August 2020. https://doi.org/10.31234/osf.io/jnxcu.

‘Missing School Is “Worse than Virus for Children”’. BBC News, 23 August 2020, sec. UK. https://www.bbc.com/news/uk-53875410.

Sun, W., McCroskery, S., Liu, W.-C., Leist, S. R., Liu, Y., Albrecht, R. A., Slamanig, S., Oliva, J., Amanat, F., Schäfer, A., Dinnon, K. H., Innis, B. L., García-Sastre, A., Krammer, F., Baric, R. S., & Palese, P. (2020). A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine. BioRxiv, 2020.07.30.229120. https://doi.org/10.1101/2020.07.30.229120

Bangaru, S., Ozorowski, G., Turner, H. L., Antanasijevic, A., Huang, D., Wang, X., Torres, J. L., Diedrich, J. K., Tian, J.-H., Portnoff, A. D., Patel, N., Massare, M. J., Yates, J. R., Nemazee, D., Paulson, J. C., Glenn, G., Smith, G., & Ward, A. B. (2020). Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. BioRxiv, 2020.08.06.234674. https://doi.org/10.1101/2020.08.06.234674

Ledford, H. (2020). What the immune response to COVID-19 says about the prospects for a vaccine. Nature. https://doi.org/10.1038/d41586-020-02400-7

Marshall, M. (n.d.). Everything you need to know about Russia’s coronavirus vaccine claims. New Scientist. Retrieved August 18, 2020, from https://www.newscientist.com/article/2251722-everything-you-need-to-know-about-russias-coronavirus-vaccine-claims/

Lo, A. W., Siah, K. W., & Wong, C. H. (2020). Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs (Working Paper No. 27176; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27176

CNN, A. V., Holly Yan and Christina Maxouris. (n.d.). FDA won’t ‘cut corners’ to approve a Covid-19 vaccine, commissioner says. CNN. Retrieved 12 August 2020, from https://www.cnn.com/2020/08/10/health/us-coronavirus-monday/index.html

CNN, C. M. (n.d.). Previous vaccines and masks may hold down Covid-19, some researchers say. CNN. Retrieved 12 August 2020, from https://www.cnn.com/2020/08/11/health/us-coronavirus-tuesday/index.html

Yong, Ed. ‘Immunology Is Where Intuition Goes to Die’. The Atlantic, 5 August 2020. https://www.theatlantic.com/health/archive/2020/08/covid-19-immunity-is-the-pandemics-central-mystery/614956/.

A Vaccine Reality Check. (n.d.). MSN. Retrieved August 9, 2020, from https://www.msn.com/en-us/news/us/a-vaccine-reality-check/ar-BB178Yaf

Acemoglu, D., Chernozhukov, V., Werning, I., & Whinston, M. D. (2020). Optimal Targeted Lockdowns in a Multi-Group SIR Model (Working Paper No. 27102; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27102

CNN, J. G., Naomi Thomas, Dana Vigue and Jacqueline Howard. (n.d.). Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest. CNN. Retrieved August 2, 2020, from https://www.cnn.com/2020/07/20/health/oxford-covid-19-vaccine-results-cansino-pfizer-study/index.html

The World’s Supply Chain Isn’t Ready for a Covid-19 Vaccine. (2020, July 25). Bloomberg.Com. https://www.bloomberg.com/news/articles/2020-07-25/the-supply-chain-to-save-the-world-is-unprepared-for-a-vaccine

Younes, G. A., Ayoubi, C., Ballester, O., Cristelli, G., de Rassenfosse, G., Foray, D., Gaule, P., Pellegrino, G., van den Heuvel, M., Webster, B., & Zhou, L. (2020). COVID-19_Insights from Innovation Economists [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/b5zae

Younes, G. A., Ayoubi, C., Ballester, O., Cristelli, G., de Rassenfosse, G., Foray, D., Gaule, P., van den Heuvel, M., Webster, B., & Zhou, L. (2020). COVID-19: Insights from Innovation Economists (with French executive summary) [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/65pgr

Thorneloe, R., Wilcockson, H. E., PhD, Lamb, M., Jordan, C. H., & Arden, M. (2020, July 20). Willingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: a UK-wide survey. https://doi.org/10.31234/osf.io/fs9wk

Sehgal, D. (2020). Analysis of Vaccines to tackle COVID-19 with Patent Review [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/q96wj

Herper, M. (2020, July 1). Covid-19 vaccine from Pfizer and BioNTech shows positive results. CNBC. https://www.cnbc.com/2020/07/01/coronavirus-vaccine-from-pfizer-and-biontech-shows-positive-results-report-says.html

Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S. P., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fonter-Garfias, C., Shi, P.-Y., Tuereci, O., Tompkins, K. R., Walsh, E. E., … Jansen, K. U. (2020). Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report. MedRxiv, 2020.06.30.20142570. https://doi.org/10.1101/2020.06.30.20142570

A COVID-19 vaccine has passed its first human trial. But is it the frontrunner? (2020, May 29). Science. https://www.nationalgeographic.com/science/2020/05/coronavirus-vaccine-passes-first-human-trial-but-is-it-frontrunner-cvd/

Larry Brilliant on How Well We Are Fighting Covid-19. (n.d.). Wired. Retrieved July 18, 2020, from https://www.wired.com/story/larry-brilliant-on-how-well-are-we-fighting-covid-19/

Ivers, Louise C., and Daniel J. Weitzner. ‘Can Digital Contact Tracing Make up for Lost Time?’ The Lancet Public Health 0, no. 0 (16 July 2020). https://doi.org/10.1016/S2468-2667(20)30160-2.

Richards, A. D. (2020). Ethical Guidelines for Deliberately Infecting Volunteers with COVID-19 [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/jb7gq

Gewin, Virginia. ‘Remote Controller’. Nature 583, no. 7816 (13 July 2020): 484–484. https://doi.org/10.1038/d41586-020-02073-2.

Corbett, K. S., Edwards, D., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K. H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch, E. J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B. M., … Graham, B. S. (2020). SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness. BioRxiv, 2020.06.11.145920. https://doi.org/10.1101/2020.06.11.145920

Interactive Heat Map - SARS-CoV-2 - Bloom Lab

Starr, T. N., Greaney, A. J., Hilton, S. K., Crawford, K. H., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., Veesler, D., & Bloom, J. D. (2020). Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding [Preprint]. Microbiology. https://doi.org/10.1101/2020.06.17.157982

Bloom Lab. (2020, June 18). "We've experimentally measured how all amino-acid mutations to the #SARSCoV2 spike RBD affect ACE2 binding and expression of folded protein in a deep mutational scanning study led by @tylernstarr & Allie Greaney:https://biorxiv.org/content/10.1101/2020.06.17.157982v1 Why is this important? (1/n)" Twitter. https://twitter.com/jbloom_lab/status/1273468539484213248

Bergstrom, C. T. (2020, June 14). "1. Another day, another blog post of #COVID19 misinformation making the rounds." Twitter. https://twitter.com/CT_Bergstrom/status/1272007583222513664

The quest for a vaccine could restore faith in big pharma. (n.d.). The Economist. Retrieved June 8, 2020, from https://www.economist.com/business/2020/06/04/the-quest-for-a-vaccine-could-restore-faith-in-big-pharma

Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., Hagglof, T., Oliveira, T. Y., Viant, C., Hurley, A., Hoffmann, H.-H., Millard, K. G., Kost, R. G., Cipolla, M., Gordon, K., … Nussenzweig, M. C. (2020). Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals [Preprint]. Immunology. https://doi.org/10.1101/2020.05.13.092619

Crotty, S. (2020, May 14). "Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multiple ways, including coronavirus vaccines. @ljiresearch cell.com/cell/fulltext/..." Twitter. https://twitter.com/profshanecrotty/status/1261052353773363200

Sjåstad, H., Teigen, K. H., & Van Bavel, J. J. (2020, June 5). The best-case heuristic in risk prediction: Hopes and fears in a global health pandemic (COVID-19). https://doi.org/10.31234/osf.io/pcj4f

Diseases, T. L. I. (2020). COVID-19: Endgames. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30298-X

Matthews, D. (2020, May 20). How exposing healthy volunteers to Covid-19 for vaccine testing would work. Vox. https://www.vox.com/future-perfect/2020/5/20/21258725/covid-19-human-challenge-trials-vaccine-update-sars-cov-2

Kurzweil, R. (2020 May 19). AI-Powered Biotech Can Help Deploy a Vaccine In Record Time. Wired. https://www.wired.com/story/opinion-ai-powered-biotech-can-help-deploy-a-vaccine-in-record-time/

The First Shot: Inside the Covid Vaccine Fast Track. (n.d.). Wired. Retrieved May 30, 2020, from https://www.wired.com/story/moderna-covid-19-vaccine-trials/

Bertin, P., Nera, K., & Delouvée, S. (2020). Conspiracy beliefs, chloroquine, and the rejection of vaccination: A conceptual replication-extension in the COVID-19 pandemic context [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/rz78k

Eichenbaum, M., Rebelo, S., & Trabandt, M. (2020). The Macroeconomics of Epidemics (No. w26882; p. w26882). National Bureau of Economic Research. https://doi.org/10.3386/w26882

Draulans, D. (2020, May 8). ‘Finally, a virus got me.’ Scientist who fought Ebola and HIV reflects on facing death from COVID-19. Science | AAAS. https://www.sciencemag.org/news/2020/05/finally-virus-got-me-scientist-who-fought-ebola-and-hiv-reflects-facing-death-covid-19

Hargreaves, J., Davey, C., Hargreaves, J., Davey, C., Auerbach, J., Blanchard, J., Bond, V., Bonell, C., Burgess, R., Busza, J., Colbourn, T., Cowan, F., Doyle, A., Hakim, J., Hensen, B., Hosseinipour, M., Lin, L., Johnson, S., Masuka, N., … Yekeye, R. (2020). Three lessons for the COVID-19 response from pandemic HIV. The Lancet HIV, S2352301820301107. https://doi.org/10.1016/S2352-3018(20)30110-7

Rusbridger, Alan. ‘Sage Coronavirus Expert: We’ve Had an Epidemic That to Some Degree Could Have Been Avoided’. Accessed 29 May 2020. https://www.prospectmagazine.co.uk/science-and-technology/alan-rusbridger-sage-jeremy-farrar-covid-19-coronavirus-dominic-cummings-herd-immunity.

Cohen, J., & Kupferschmidt, K. (2020). Countries test tactics in ‘war’ against COVID-19. Science, 367(6484), 1287–1288. https://doi.org/10.1126/science.367.6484.1287

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., Marrama, D., de Silva, A. M., Frazier, A., Carlin, A., Greenbaum, J. A., Peters, B., Krammer, F., Smith, D. M., Crotty, S., & Sette, A. (2020). Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell, S0092867420306103. https://doi.org/10.1016/j.cell.2020.05.015

New Norms And Difficult Dogs: The Week’s Best Psychology Links. (2020, May 15). BPS. https://digest.bps.org.uk/2020/05/15/new-norms-and-difficult-dogs-the-weeks-best-psychology-links/

Callaway, E. (2020). The race for coronavirus vaccines: A graphical guide. Nature, 580(7805), 576–577. https://doi.org/10.1038/d41586-020-01221-y

Hoffman, T. & Glasziou, P. (2020 May 05). Coronavirus: What if a vaccine doesn’t work? World Economic Forum. https://www.weforum.org/agenda/2020/05/vaccine-coronavirus-alternatives-covid19-vaccinations/

Hodgson, C. (2020, May 13). WHO’s chief scientist offers bleak assessment of challenges ahead. https://www.ft.com/content/69c75de6-9c6b-4bca-b110-2a55296b0875

Ball, P. (2020). Anti-vaccine movement could undermine efforts to end coronavirus pandemic, researchers warn. Nature, 581(7808), 251–251. https://doi.org/10.1038/d41586-020-01423-4

Cobey, S. (2020). Modeling infectious disease dynamics. Science, 368(6492), 713–714. https://doi.org/10.1126/science.abb5659

Australian Government Department of Health (2020, April 1). Coronavirus (COVID-19) – Restrictions on entry into and visitors to aged care facilities [Text]. https://www.health.gov.au/resources/publications/coronavirus-covid-19-restrictions-on-entry-into-and-visitors-to-aged-care-facilities

Shental, N., Levy, S., Skorniakov, S., Wuvshet, V., Shemer-Avni, Y., Porgador, A., & Hertz, T. (2020). Efficient high throughput SARS-CoV-2 testing to detect asymptomatic carriers. MedRxiv, 2020.04.14.20064618. https://doi.org/10.1101/2020.04.14.20064618

Expert comments about herd immunity | Science Media Centre. (n.d.). Retrieved April 14, 2020, from https://www.sciencemediacentre.org/expert-comments-about-herd-immunity/

Bergstrom, C. T., & Dean, N. (2020, May 1). Opinion | What the Proponents of ‘Natural’ Herd Immunity Don’t Say. The New York Times. https://www.nytimes.com/2020/05/01/opinion/sunday/coronavirus-herd-immunity.html

Makoni, M. (2020). Keeping COVID-19 at bay in Africa. The Lancet Respiratory Medicine, S2213260020302198. https://doi.org/10.1016/S2213-2600(20)30219-8

Adams, E. R., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E., Bell, J., Berry, T., Bibi, S., Carroll, M., Chinnakannan, S., Clutterbuck, E., Cornall, R. J., Crook, D. W., Silva, T. D., Dejnirattisai, W., Dingle, K. E., Dold, C., Eyre, D. W., … Sanchez, V. (2020). Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays. MedRxiv, 2020.04.15.20066407. https://doi.org/10.1101/2020.04.15.20066407

Forum, W. E. (n.d.). Strategic Intelligence | World Economic Forum. Stategic Intelligence. Retrieved April 24, 2020, from https://intelligence.weforum.org

Newton, P. N., Bond, K. C., Adeyeye, M., Antignac, M., Ashenef, A., Awab, G. R., Babar, Z.-U.-D., Bannenberg, W. J., Bond, K. C., Bower, J., Breman, J., Brock, A., Caillet, C., Coyne, P., Day, N., Deats, M., Douidy, K., Doyle, K., Dujardin, C., … Zaman, M. (2020). COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. The Lancet Global Health, S2214109X20301364. https://doi.org/10.1016/S2214-109X(20)30136-4

Evidence Tracker: COVID-19

Government of Canada. (2020). Government of Canada funds 49 additional COVID-19 research projects – Details of the funded projects. Canada.ca. https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-research-projects-details-of-the-funded-projects.html

EU boosts efforts to adjust R&D programmes to virus crisis. (n.d.). Science|Business. Retrieved April 15, 2020, from https://sciencebusiness.net/news/eu-boosts-efforts-adjust-rd-programmes-virus-crisis

Coronavirus misinformation and vaccine research among key priorities for public | Imperial News | Imperial College London. (n.d.). Imperial News. Retrieved April 8, 2020, from https://www.imperial.ac.uk/news/196696/coronavirus-misinformation-vaccine-research-among-priorities/

Open Letter to the Research and Innovation Community—UK Research and Innovation. (n.d.). Retrieved April 9, 2020, from https://www.ukri.org/news/open-letter-to-the-research-and-innovation-community/

Societal Responses to and Preparedness for Emerging Viral Infections – 2020. (n.d.). Novo Nordisk Fonden. Retrieved April 16, 2020, from https://novonordiskfonden.dk/da/grants/societal-responses-to-and-preparedness-for-emerging-viral-infections-2020/